RKLB
Rocket Lab USA, Inc.
RKLB offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
VRSK
Verisk Analytics, Inc.
VRSK has the edge over RKLB overall, supported by lower modeled downside and stronger valuation.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
VRSK Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Stable |
VRSK's profitability and cash flow are currently healthy, and its revenue and balance sheet are stable.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
VRSK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 25x | $206 | — |
| Cheap | 29x | $191 | -7.4% |
| Current | 31x | $206 | — |
| Fair | 45x | $294 | +42% |
| Expensive | 59x | $386 | +87% |
Historical ranges are pointers, not guarantees.
VRSK's PE is in its cheap range at 31x. If earnings grow as analysts expect, today's price would be 25x next year's earnings.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RKLB's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
VRSK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for VRSK, with profitability improving.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
VRSK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $8.42 | +28% |
| Q3 2026 | $6.59 | +0.3% |
| Q2 2026 | $6.50 | 0% |
| Q1 2026 | $6.56 | -4.1% |
| Q4 2025 | $6.48 | -3.4% |
| Q3 2025 | $6.57 | +3.1% |
| Q2 2025 | $6.50 | +6.2% |
| Q1 2025 | $6.84 | +29% |
| Q4 2024 | $6.71 | +61% |
VRSK has the edge over RKLB on earnings quality, reporting a profit while its opponent remains loss making.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB has the edge over VRSK on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB's operating margin was −30% last quarter, up 8.5 points from the same quarter a year ago.
VRSK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $809M | +5.3% |
| Q2 2026 | $806.3M | +4.4% |
| Q1 2026 | $782.6M | +3.9% |
| Q4 2025 | $778.8M | +5.9% |
| Q3 2025 | $768.3M | +5.9% |
| Q2 2025 | $772.6M | +7.8% |
| Q1 2025 | $753M | +7% |
| Q4 2024 | $735.6M | +8.6% |
VRSK's revenue has grown year over year for 12 quarters in a row: $809M last quarter, up 5.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 45% | +0.1 points |
| Q2 2026 | 45% | -0.8 points |
| Q1 2026 | 45% | +1.2 points |
| Q4 2025 | 40% | -2.7 points |
| Q3 2025 | 45% | +2.1 points |
| Q2 2025 | 46% | +1.4 points |
| Q1 2025 | 44% | +0.2 points |
| Q4 2024 | 43% | +6 points |
VRSK has the edge over RKLB on profitability, with a higher operating margin.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
VRSK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $200M | -40% |
| Q2 2026 | $297.9M | +58% |
| Q1 2026 | $326.4M | -17% |
| Q4 2025 | $276.1M | +38% |
| Q3 2025 | $336.1M | +40% |
| Q2 2025 | $188.7M | +23% |
| Q1 2025 | $391M | +23% |
| Q4 2024 | $200M | +2% |
VRSK has the edge over RKLB on cash generation, producing positive trailing cash flow while its opponent burns cash.
RKLB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.6% | +22.6M shares |
| 1 year | +23% | +124M shares |
| 3 years | +35% | +168M shares |
| 5 years | +46% | +204M shares |
RKLB has 652M diluted shares, up 23% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
VRSK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.2% | -1.6M shares |
| 1 year | -7.7% | -10.7M shares |
| 3 years | -11% | -16.5M shares |
| 5 years | -21% | -33.6M shares |
| Available history | -22% | -37.3M shares |
VRSK has the edge over RKLB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $100.1M |
| Q2 2026 | $170.1M |
| Q1 2026 | $1.4B |
| Q4 2025 | $223.8M |
| Q3 2025 | $100.1M |
| Q2 2025 | $100M |
| Q1 2025 | $170.1M |
| Q4 2024 | $315M |
VRSK spent $1.9B buying back its own shares over the past year, up 177% from the year before.
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
VRSK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.4x | Moderate |
| Q2 2026 | 2.4x | Moderate |
| Q1 2026 | 2.4x | Moderate |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 1.6x | Healthy |
| Q2 2025 | 1.7x | Healthy |
| Q1 2025 | 1.7x | Healthy |
| Q4 2024 | 1.9x | Healthy |
VRSK's net debt is about 2.4 years of its operating earnings (EBITDA), up from 1.6 years a year ago.
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
VRSK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.8 | Neutral |
| Stochastic | 71.3 | Neutral |
VRSK's weekly RSI is 60 (neutral) and its Stochastic is 71 (neutral).
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
VRSK PE vs Industrials Sector
| Metric | VRSK | Sector median | Relative |
|---|---|---|---|
| PE | 31x | 24x | 30% above |
| PE % | 23 | 58 | 35 pts below |
VRSK is trading at 31x earnings, a 30% premium to the Industrials sector's median of 24x.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB's trend is mixed: it's above three of its five weekly moving averages, and 104% above its 200-week average.
VRSK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $188.1 | 9.7% above |
| 20 week MA | $188.3 | 9.6% above |
| 50 week MA | $191.7 | 7.6% above |
| 100 week MA | $234.5 | 12% below |
| 200 week MA | $236.2 | 13% below |
VRSK has bounced recently, but its long-term trend is still down: it's above its 8-, 20- and 50-week averages, but 13% below its 200-week average.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB's yearly returns have swung widely, from +392% in 2024 to −69% in 2022. It's down 9.3% so far in 2026.
VRSK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.6 | $201.2 | +35% |
| 2021 | $201.2 | $225.5 | +12% |
| 2022 | $225.5 | $175.6 | -22% |
| 2023 | $175.6 | $238.9 | +36% |
| 2024 | $238.9 | $277.3 | +16% |
| 2025 | $277.3 | $220.3 | -21% |
| 2026 YTD | $220.3 | $206.3 | -6.4% |
VRSK has the edge over RKLB on returns for 2026, with the stronger performance.